Parabase Genomics is committed to improving neonatal care through the development of early diagnostics for actionable inherited disorders. They've pioneered post-natal, diagnostic genetic testing and were in need of a partner for their marketing, kitting and distribution needs. In my position as MarComm manager for TAGmedica, I led the creative development and design for their inaugural test kit which requires just one drop of a newborn's blood in order to test for rare, monogenic diseases, like hematologic disorders, and hearing loss.
"When hospitals and centers for cell line creation join forces, it's possible for the community to create large collections of genomically characterized disease models at scale and determine best practices to ensure open, unfettered access to those new models for the scientific community." That is the mission of the Cell Line Factory.
In my position as MarComm manager for TAGmedica, I led the creative development and design for the Cell Line Factory's first test kit, 'Cancer Cell Line Project', which actively seeks new collaborators to submit appropriately consented and cryopreserved samples for cell line initiation (including from other diseases).
One of the creative challenges we solved for in this main collateral piece for Good Start Genetics, was developing simple, visual devices that would clearly explain the process and benefits of Good Start Genetics' patented 'Next-Generation Sequencing' technology.
Zika Virus Real-time RT-PCR is intended for the qualitative detection of RNA from Zika virus in human plasma, serum or urine. Healthcare providers are strongly encouraged to collect serum specimens alongside other specimen types to provide additional opportunities for diagnosing Zika virus infection in cases when PCR tests are negative.
In my position as MarComm manager for The Allied Group/TAGmedica, I led the creative
development and design for this first Zika Virus, saliva test kit developed by Eurofins,
This is the first test kit Good Start Genetics distributed and the design of this kit began my relationship with GSG as their creative counsel, as well as The Allied Group's long-standing relationship with Good Start Genetics as one of their major clients.
I'm still proud that our talented design team at The Allied Group developed this initial, simple, influential and ultimately pivotal design work for both companies.
One of the creative challenges we solved for in this main collateral piece for Good Start Genetics, was developing a simple, visual device that would clearly convey the difference between standard genotyping versus Good Start Genetics' patented 'Next-Generation Sequencing' technology.
In the words of Foundation Medicine, "FoundationOne is a validated comprehensive genomic profile (CGP) for solid tumors. The test is designed to provide physicians with clinically actionable information to guide treatment decisions for patients based on the genomic profile of their disease. Test results provide information about clinically significant alterations, potential targeted therapies, available clinical trials, and quantitative markers of response for immunotherapy."
In my position as MarComm manager for The Allied Group/TAGmedica, I led the creative development and design for the diagnostic test kits for FoundationOne and Clinical Trials specimen collection developed by Foundation Medicine.